🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yu Mi Kang

Brigham and Women's Hospital

ORCID: 0000-0002-6272-0666

Also affiliated with Joslin Diabetes Center, Harvard University, Massachusetts General Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis”.

Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

Circulation(2024)10.1161/circulationaha.124.069568

N/A

0.770DataRank · unranked

169 citations

Yu Mi Kang, KyungAh Im, Brendon L. Neuen, Stefan D. Anker, Deepak L. Bhatt +24 more

Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence–TIMI 73b trial

American Heart Journal(2025)10.1016/j.ahj.2025.02.022

N/A

0.453DataRank · unranked

12 citations

Nicholas Marston, Thomas A Prohaska, Veronica J. Alexander, André Zimerman, Filipe A. Moura +9 more

Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia

American Heart Journal(2025)10.1016/j.ahj.2025.03.003

N/A

0.408DataRank · unranked

10 citations

Brian A. Bergmark, Veronica J. Alexander, Ewa Karwatowska‐Prokopczuk, Yu Mi Kang, Filipe A. Moura +8 more